Clinical value of 18FDG PET/MRI in muscle-invasive, locally advanced, and metastatic bladder cancer-Reference-Cited by-同舟云学术

Clinical value of 18FDG PET/MRI in muscle-invasive, locally advanced, and metastatic bladder cancer

Published:2021-11 Issue:11 Volume:39 Page:787.e17-787.e21
ISSN:1078-1439
Container-title:Urologic Oncology: Seminars and Original Investigations
language:en
Short-container-title:Urologic Oncology: Seminars and Original Investigations

Author:

Civelek Ali Cahid,Niglio Scot A.,Malayeri Ashkan A.,Lin Jeffrey,Gurram Sandeep,Chalfin Heather J.,Turkbey Baris,Valera Vladimir,Steinberg Seth M.,Apolo Andrea B.

Funder

American Association for Dental Research

National Institutes of Health

Doris Duke Charitable Foundation

Genentech

Publisher

Elsevier BV

Subject

Urology,Oncology

Reference22 articles.

1. Cancer statistics, 2020;Siegel;CA Cancer J Clin,2020

2. Advances in medical imaging for the diagnosis and management of common genitourinary cancers;Bagheri;Urol Oncol,2017

3. NCCN clinical practice guidlines in oncology bladder cancer,2020

4. Use of Intravenous Gadolinium-Based Contrast Media in Patients With Kidney Disease: Consensus Statements from the American College of Radiology and the National Kidney Foundation;Weinreb;Kidney Med,2021

5. Multiparametric magnetic resonance imaging for bladder cancer:dDevelopment of VI-RADS (Vesical Imaging-Reporting And Data System);Panebianco;Eur Urol,2018

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Performance of 18F-FDG PET/MRI and its parameters in staging and neoadjuvant therapy response evaluation in bladder cancer;iScience;2024-05

2. Organ preservation in muscle-invasive urothelial bladder cancer;Current Opinion in Oncology;2024-03-08

3. Head-to-head comparison of <sup>18</sup>F-FDG PET/CT and <sup>18</sup>F-FDG PET/MRI for lymph node metastasis staging in non-small cell lung cancer: a meta-analysis;Diagnostic and Interventional Radiology;2024-03-01

4. Elafibranor emerged as a potential chemotherapeutic drug for non-muscle invasive bladder cancer;Cell Insight;2024-02

5. European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2023 Guidelines;European Urology;2024-01